Nerea Unceta-Munoz
Santander, CB, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: September 23, 2025
[Translated article] Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: September 23, 2025
Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 02, 2023
Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 27, 2023
Prevalence, Clinical Characteristics, and Management of Episodic Dyspnea in Advanced Lung Cancer Outpatients: A Multicenter Nationwide Study-The INSPIRA-DOS Study.
Journal: Journal of palliative medicine
Published: February 23, 2022
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 15, 2020
High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 30, 2020
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
Journal: Oncology research and treatment
Published: February 02, 2020
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.
Journal: Cancer chemotherapy and pharmacology
Published: October 07, 2019
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.
Journal: Cancer chemotherapy and pharmacology
Published: February 25, 2019
Durvalumab in NSCLC: latest evidence and clinical potential.
Journal: Therapeutic advances in medical oncology
Published: May 23, 2018
Risk factors associated with Clostridium difficile infection in adult oncology patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 22, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026